Tech Company Financing Transactions
Calluna Pharma Funding Round
On 1/24/2024, Calluna Pharma announced $81.1 million in Series A funding from Forbion Capital Partners, Investinor and P53.
Transaction Overview
Company Name
Announced On
1/24/2024
Transaction Type
Venture Equity
Amount
$81,130,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand operations, and develop its pipeline to multiple key clinical steps over the next 2.5 years.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Gaustadalléen 21
Oslo, 0349
Norway
Oslo, 0349
Norway
Phone
Undisclosed
Website
Email Address
Overview
At Calluna Pharma we are developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source. Our innovative therapeutic approach targets upstream amplifiers of disease offering potential applicability across a diverse array of medical conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Montana
Chief Financial Officer
Louise Kooij
Chief Marketing Officer
Jonas Hallén
Browse more venture capital transactions:
Prev: 1/24/2024: UnSkript venture capital transaction
Next: 1/24/2024: Safty venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record all VC transactions involving tech companies. All VC database entries on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs